Skip to content
Screener

Corcept Therapeutics CORT Total Cost of Revenue

Total Cost of Revenue at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
$12.51M+5.2%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$200K—
Eli Lilly logo
Eli LillyLLY
$3.27B+33.5%

Other financials

Income statement

See full
Revenue$256.1M+31.7%
Gross profit$252.1M+32.0%
Operating income$41.3M+54.8%
Net income$43.0M+22.3%
EPS (diluted)$0.36+24.1%

Balance sheet

See full
Cash & equivalents$112.3M+9.3%
Total debt$9.4M+42.6%
Total equity$705.8M+11.0%
Total assets$888.7M+10.8%

Cash flow

See full
Operating cash flow$33.5M-23.7%
CapEx$2.5M+4,335%
Free cash flow$31.0M-29.3%

Valuation

See full
Market cap$11.67B+57.0%
Enterprise value$11.57B+57.7%
P/E211.5×+156×
P/S14.1×+3.7×

Profitability

See full
Gross margin98.3%-0.1pp
Operating margin0.8%-13.5pp
Net margin6.6%-12.0pp
FCF margin12.9%-12.3pp

Returns & leverage

See full
Return on equity8.2%-13.5pp
Debt / equity0×0.0×
Current ratio2.9×-0.2×

Where this comes from

Reported directly by Corcept Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050613
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Product revenue, net256,147194,430421,050351,644
Operating expenses:
Cost of sales4,0613,4336,9445,836
Research and development53,89060,471120,155121,206
Selling, general and administrative156,896103,851302,252194,511
Total operating expenses214,847167,755429,351321,553
Income (loss) from operations41,30026,675(8,301)30,091
Interest and other income4,6315,0179,51711,219

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Corcept Therapeutics's total cost of revenue?
Corcept Therapeutics (CORT) reported total cost of revenue of $4.06M in Q2 2026.
How has Corcept Therapeutics's total cost of revenue changed year-over-year?
Corcept Therapeutics's total cost of revenue increased by 18.3% year-over-year, from $3.43M to $4.06M.
What is the long-term trend for Corcept Therapeutics's total cost of revenue?
Over 4 years (2021 to 2025), Corcept Therapeutics's total cost of revenue has grown at a 25.2% compound annual growth rate (CAGR), from $5.28M to $12.98M.
What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.

Ask your AI about Corcept Therapeutics's total cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude